Hycamtin

Active Ingredient(s): Topotecan
FDA Approved: * May 28, 1996
Pharm Company: * GLAXOSMITHKLINE
Category: Cancer

Topotecan, sold under the brand name Hycamtin among others, is a chemotherapeutic agent medication that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types. After GlaxoSmithKline received final FDA approval for topotecan on October 15, 2007, it became the first topoisomerase I inhibitor for oral use.[citation nee... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Hycamtin HYCAMTIN;0;25;mg
Hycamtin 0.25 mg Oral Capsule
NDC: 0007-4205
Labeler:
Glaxosmithkline LLC
Hycamtin HYCAMTIN;1;mg
Hycamtin 1 mg Oral Capsule
NDC: 0007-4207
Labeler:
Glaxosmithkline LLC
Hycamtin HYCAMTIN;0;25;mg
Hycamtin .25 mg Oral Capsule
NDC: 0078-0672
Labeler:
Novartis Pharmaceuticals Corporation
Hycamtin HYCAMTIN;0;25;mg
Hycamtin .25 mg Oral Capsule
NDC: 12064-000
Labeler:
Glaxosmithkline Manufacturing Spa
Hycamtin HYCAMTIN;1;mg
Hycamtin 1 mg Oral Capsule
NDC: 12064-001
Labeler:
Glaxosmithkline Manufacturing Spa
Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0007-4201
Labeler:
Glaxosmithkline LLC
Hycamtin 1 mg Oral Capsule
NDC: 0078-0673
Labeler:
Novartis Pharmaceuticals Corporation
Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0078-0674
Labeler:
Novartis Pharmaceuticals Corporation
Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 12064-002
Labeler:
Glaxosmithkline Manufacturing Spa